Lewis Gryziewicz
Consejero General en ANAPTYSBIO, INC. .
Perfil
Lewis Gryziewicz is currently the Vice President-Regulatory Affairs at AnaptysBio, Inc. He previously held the same position at Macrocure Ltd.
in 2015.
Gryziewicz earned an MBA from Fairleigh Dickinson University in 1996, a doctorate from The University of Colorado in 2006, and an undergraduate degree from the University of the Sciences in Philadelphia in 1986.
Cargos activos de Lewis Gryziewicz
| Empresas | Cargo | Inicio |
|---|---|---|
| ANAPTYSBIO, INC. | Consejero General | 01/01/2019 |
Antiguos cargos conocidos de Lewis Gryziewicz.
| Empresas | Cargo | Fin |
|---|---|---|
| MACROCURE LTD | Consejero General | 31/12/2015 |
Formación de Lewis Gryziewicz.
| The University of Colorado | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
| University of the Sciences in Philadelphia | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ANAPTYSBIO, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Macrocure Ltd.
 Macrocure Ltd. Medical SpecialtiesHealth Technology Macrocure Ltd. is a clinical-stage biotechnology company, which engages in the development and commercialization of advanced cell therapy products. Its product, CureXcell, is an advanced wound care therapy that treat such wounds by injecting living human white blood cells that have been activate to facilitate the healing process. The company was founded by David Ben-Ami on January 14, 2008 and is headquartered in Petach Tikva, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Lewis Gryziewicz
